Maryland Subject | Drugs | Engrossed

Type

Status

State	Bill	Status	Summary/Title	Last Action
MD	SB986	Engross 50%	Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Co... [Detail][Text][Discuss]	2024-04-06 To House Rules and Executive Nominations Committee
MD	HB1277	Engross 50%	Prohibiting a use of force report from including information that is prohibited from disclosure by State or federal law; requiring an employer of a security guard providing security guard services on the premises of a health care facility to report e... [Detail][Text][Discuss]	2024-04-05 To Senate Rules Committee
MD	SB595	Engross 50%	Requiring administrators, carriers, and pharmacy benefits managers to include certain cost sharing amounts paid by or on behalf of an enrollee or a beneficiary when calculating the enrollee's or beneficiary's contribution to a cost sharing requiremen... [Detail][Text][Discuss]	2024-04-05 House Refuses Recede
MD	HB1396	Engross 50%	Requiring the Maryland Department of Health to conduct a certain study on linkages between levels of care within the substance use disorder treatment and recovery continuum of care; and requiring the Department to report the results of the study and ... [Detail][Text][Discuss]	2024-03-19 To Senate Finance Committee
MD	HB876	Engross 50%	Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from excluding coverage for certain specialty drugs that are administered or dispensed by a provider that meets certain criteria; and requiring the rei... [Detail][Text][Discuss]	2024-03-18 To Senate Finance Committee
MD	HB726	Engross 50%	Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app... [Detail][Text][Discuss]	2024-03-14 To Senate Finance Committee